181 filings
Page 5 of 10
DEFA14A
xr7oq7q 4k
4 Apr 23
Additional proxy soliciting materials
7:19pm
8-K
5xybc b65gnz
4 Apr 23
Other Events
9:01am
425
abfaepd0dtwagmfa
4 Apr 23
Business combination disclosure
8:53am
DEFA14A
y2lr9h3
3 Apr 23
Additional proxy soliciting materials
4:05pm
8-K
3ct16 occ78
31 Mar 23
Other Events
4:35pm
424B3
x7fq1l czgg4
31 Mar 23
Prospectus supplement
4:33pm
DEFA14A
at7gldcxr4 h02bd
30 Mar 23
Additional proxy soliciting materials
4:09pm
DEFA14A
wvjxm5 a62kg
23 Mar 23
Additional proxy soliciting materials
4:04pm
EFFECT
1dv6sgo jnb6
9 Mar 23
Notice of effectiveness
12:15am
424B3
0qt bdw4dlsxg
8 Mar 23
Prospectus supplement
4:18pm
CORRESP
1ns4t2hv
6 Mar 23
Correspondence with SEC
12:00am
8-K
4jg ft3isriz
2 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
p1gq36e1gj 68g5p9bfy
24 Feb 23
Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results
7:34am
CORRESP
6sou7
24 Feb 23
Correspondence with SEC
12:00am
UPLOAD
ruav2fgsj3x xzikc
14 Feb 23
Letter from SEC
12:00am
CORRESP
b6ybsjwt6if3
9 Feb 23
Correspondence with SEC
12:00am